ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell

2026-02-01 00:54:11 ET

Intro

ResMed ( RMD ) is a $37 billion powerhouse that sees itself as a "36-year-old startup" in the field of sleep and breathing health. It dominates as the #1 provider in 140+ countries with a 50–60% market share in sleep apnea devices like CPAP (“Continuous Positive Airway Pressure”) machines, masks, and SaaS platforms/digital solutions. The company targets obstructive sleep apnea (OSA) and COPD for better rest and vitality....

Read the full article on Seeking Alpha

For further details see: